1.76
+0.03(+1.73%)
Currency In USD
| Previous Close | 1.73 |
| Open | 1.68 |
| Day High | 1.76 |
| Day Low | 1.64 |
| 52-Week High | 13.52 |
| 52-Week Low | 1.64 |
| Volume | 296,209 |
| Average Volume | 3.25M |
| Market Cap | 9.2M |
| PE | -0.18 |
| EPS | -10.01 |
| Moving Average 50 Days | 2.31 |
| Moving Average 200 Days | 3.96 |
| Change | 0.03 |
If you invested $1000 in Beyond Air, Inc. (XAIR) since IPO date, it would be worth $29.83 as of November 10, 2025 at a share price of $1.76. Whereas If you bought $1000 worth of Beyond Air, Inc. (XAIR) shares 5 years ago, it would be worth $16.15 as of November 10, 2025 at a share price of $1.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beyond Air® Secures Up to $32 Million to Accelerate Growth
GlobeNewswire Inc.
Nov 05, 2025 1:00 PM GMT
Enters agreements for a $12 million promissory note and a $20 million equity line of credit with Streeterville Capital Proforma cash, cash equivalents, restricted cash and marketable securities of $22.9 million as of September 30, 2025, including $12
Beyond Air Schedules Second Fiscal Quarter 2026 Financial Results Conference Call and Webcast
GlobeNewswire Inc.
Oct 23, 2025 12:00 PM GMT
GARDEN CITY, N.Y., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve th
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
GARDEN CITY, N.Y., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve t